Vistagen Therapeutics, Inc. Annual Earnings Per Share, Diluted in USD/shares from 2010 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2010 to 2023.
  • Vistagen Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -0.42 USD/shares, a 36.4% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2023 was -1.52 USD/shares, a 82.1% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2022 was -8.51 USD/shares.
  • Vistagen Therapeutics, Inc. annual Earnings Per Share, Diluted for 2015 was -29.1 USD/shares, a 174% decline from 2014.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$6.99 +82.1% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-11
2022 -$9 Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2015 -$29 -$19 -174% Apr 1, 2015 Mar 31, 2016 10-K 2016-06-24
2014 -$11 -$7 -178% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 -$4 -$4 -18950% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 $0 +$0.81 +97.6% Apr 1, 2012 Mar 31, 2013 10-Q 2014-08-12
2011 -$1 +$0.98 +54.1% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 -$2 Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.